Kyntra Bio, Inc. (KYNB) — Cash Flow Quality Index

Latest as of March 2025: 0.59x

Kyntra Bio, Inc. (KYNB) has a Cash Flow Quality Index of 0.59x as of March 2025. Operating cash flow of $2.72 Million is below net income of $4.64 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Kyntra Bio, Inc. cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

0.59x
Operating CF / Net Income

Operating Cash Flow

$2.72 Million
USD

Net Income

$4.64 Million
USD

Data as of

Mar 2025
Most recent filing

Kyntra Bio, Inc. Cash Flow Quality Index (2025–2025)

Historical Cash Flow Quality Index for Kyntra Bio, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Kyntra Bio, Inc. to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Kyntra Bio, Inc. (2025–2025)

Year-by-year earnings quality comparison for Kyntra Bio, Inc.. For live market cap and the full company financial profile, see Kyntra Bio, Inc. (KYNB) total market value.

Year Quality Index Operating CF (USD) Net Income YoY Change
2025 -0.03x $-4.77 Million $183.45 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.